M. A. Clark et al. / Tetrahedron Letters 45 (2004) 7129–7131
7131
1. Experimental procedures
1.1. Pip-rhodafluor 4
spectrometer was funded through NSF Grant CHE-
9808061. We thank Carolyn Woodroofe for supplying
compound 3 and Elizabeth Nolan for her assistance in
preparing this manuscript.
To a solution of 2 (200mg, 1.12mmol) in 10mL of TFA
was added compound 3 (1.314g, 4.50mmol), following
which the solution was heated to reflux for 3d. The
crude product was isolated by removal of the TFA
under reduced pressure. Column chromatography on
silica gel (100% acetone, 100% MeOH) yielded 4 as a
bright red solid (435mg, 70.6%).
References and notes
1. (a) Clark, M. A.; Duffy, K.; Tibrewala, J.; Lippard, S. J.
Org. Lett. 2003, 5, 2051; (b) Burdette, S. C.; Lippard, S. J.
Coord. Chem. Rev. 2001, 216–217, 333; (c) Franz, K. J.;
Singh, N.; Spingler, B.; Lippard, S. J. Inorg. Chem. 2000,
39, 4081.
2. Fluorescein derivatives that contain an oxygen and
nitrogen substituent will be referred to as rhodafluors;
they are also termed rhodols or fluorhods.
3. Zhang, X.-X.; Buchwald, S. L. J. Org. Chem. 2000, 65,
8027.
4. Burdette, S. C.; Frederickson, C. J.; Bu, W.; Lippard, S. J.
J. Am. Chem. Soc. 2003, 125, 1778.
1.2. Pip-naphthorhodafluor 7
Naphthol 6 (7mg, 0.027mmol) and benzophenone 3
(13mg, 0.046mmol) were combined in TFA (250lL)
in a sealed tube and heated to 125°C for 3h. The solu-
tion was evaporated and the residue chromatographed
on silica with 9:1 DCM/MeOH (1% TFA added during
chromatography to facilitate elution of the product).
This procedure afforded 7 (11mg, 69%) as a purple solid.
5. For 4: 1H NMR (400MHz, CD3CN) 8.71 (2H, br s),
7.97 (1H, d, J = 7.5Hz), 7.75–7.66 (2H, m), 7.16 (1H, d,
J = 7.3Hz), 6.96 (1H, s), 6.74 (1H, s), 6.69–6.63 (2H, m),
3.48 (4H, m), 3.28 (4H, m); 19F NMR (282MHz, CD3OD)
98.6; HR-ESIMS 435.1100 (M+H) calcd 435.1106.
6. TCI Chemicals, Tokyo, Japan.
1.3. Imidazole-naphthol 9
6-Amino-1-naphthol 5 (92mg, 0.58mmol), 2-bromo-N-
methylimidazole
7. Jaisinghani, H. G.; Khadilkar, B. M. Tetrahedron Lett.
1997, 38, 6875.
8 (140mg, 0.87mmol), p-toluene
8. For 7: 1H NMR (300MHz, CD3OD) 8.40 (d, 1H,
J = 9Hz), 8.08 (dd, 1H, J = 1.5, 7Hz), 7.75 (m, 2H), 7.50
(dd, 1H, J = 2, 10Hz), 7.38 (d, 1H, J = 9Hz), 7.24 (d, 1H,
J = 2Hz), 7.20 (m, 1H), 7.01 (s, 1H), 6.70 (s, 1H), 6.64 (d,
1H, J = 9Hz), 3.59 (m, 4H), 3.41 (m, 4H); ESIMS 485.3
(M + H, 100%), calcd 485.1.
9. Miller, R. D.; Lee, V. Y.; Moylan, C. R. Chem. Mater.
1994, 6, 1023. Carbon tetrabromide was used instead of
dibromoethane.
sulfonic acid (132mg, 0.70mmol), and toluene (1mL)
were combined in a tube and heated to 115°C for 24h.
The solution was then partitioned between saturated
aqueous bicarbonate and EtOAc. The organic layer
was dried and evaporated. The residue was chromato-
graphed with 9:1 CH2Cl2/MeOH to afford 9 (123mg,
88%). ESIMS 240.2 (M + H, 100%), calcd 240.3.
10. Personal communication, Dr. Ryan Schoenfeld, Roche
Palo Alto.
Acknowledgements
11. For 10: 1H NMR (300MHz, CD3OD) 8.62 (d, 1H,
J = 9Hz), 8.16 (d, 1H, J = 8Hz), 7.67 (m, 2H), 7.68 (s,
1H), 7.60 (m, 1H), 7.57 (d, 1H, J = 9Hz), 7.24 (m, 2H),
7.16 (s, 1H), 7.11 (d, 1H, J = 2Hz), 6.78 (m, 1H), 3.78 (s,
3H); ESIMS 496.3 (M+H, 100%), calcd 496.1.
This work was supported by the National Institute of
General Medical Sciences (GM-65519) and the National
Science Foundation (CHE-0234951). M.A.C. is an
NRSA Fellow (GM66501-01). The MIT DCIF NMR